Expression of ACP6 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma

Oncology Reports

Volumn 15, Issue 6, 2006, Pages 1551-1555

  Ando, Takuya ^a   Ishiguro, Hideyuki ^a   Kuwabara, Yoshiyuki ^a   Kimura, Masahiro ^a   Mitsui, Akira ^a   Kurehara, Hiroki ^a   Sugito, Nobuyoshi ^a   Tomoda, Keisuke ^a   Mori, Ryota ^a   Takashima, Nobuhiro ^a   Ogawa, Ryo ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

ACP6; Esophageal cancer; Independent prognosis factor; LightCycler

Indexed keywords

LYSOPHOSPHATIDIC ACID PHOSPHATASE; MESSENGER RNA; PHOSPHATASE;

AGED; ARTICLE; BIOSYNTHESIS; ENZYMOLOGY; ESOPHAGUS TUMOR; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHORIC MONOESTER HYDROLASES; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34447546415     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.6.1551     Document Type: Article

References (19)

1. Kato J, Kuwabara Y, Mitani M, et al: Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 95: 92-95, 2001. (Pubitemid 32187079)
2. Konishi S, Ishiguro H, Shibata Y, et al: Decreased expression of DFF45/ICAD is correlated with a poor prognosis in patients with esophageal carcinoma. Cancer 95: 2473-2478, 2002. (Pubitemid 35424031)
3. Shibata Y, Haruki N, Kuwabara Y, et al: Expression of PTTG (pituitary tumor transforming gene) in esophageal cancer. Jpn J Clin Oncol 32: 233-237, 2002. (Pubitemid 43102805)
4. Shibata Y, Haruki N, Kuwabara Y, et al : Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer. Carcinogenesis 23: 1695-1699, 2002.
5. Terashita Y, Sasaki H, Haruki N, et al: Decreased peroxisome proliferator-activated receptor gamma gene expression is correlated with poor prognosis in patients with esophageal cancer. Jpn J Clin Oncol 32: 238-243, 2002. (Pubitemid 43102806)
6. Terashita Y, Ishiguro H, Haruki N, et al: Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer. Oncol Rep 12: 827-831, 2004.
7. Chakraborty TR, Vancura A, Balija VS and Haldar D: Phosphatidic acid synthesis in mitochondria. Topography of formation and transmembrane migration. J Biol Chem 274: 29786-29790, 1999.
8. Brindley DN, English D, Pilquil C, Buri K and Ling ZC: Lipid phosphate phosphatases regulate signal transduction through glycerolipids and sphingolipids. Biochim Biophys Acta 1582: 33-44, 2002. (Pubitemid 34634109)
9. Hiroyama M and Takenawa T: Purification and characterization of a lysophosphatidic acid-specific phosphatase. Biochem J 336 (Pt 2): 483-489, 1998. (Pubitemid 28564407)
10. Hiroyama M and Takenawa T: Isolation of a cDNA encoding human lysophosphatidic acid phosphatase that is involved in the regulation of mitochondrial lipid biosynthesis. J Biol Chem 274: 29172-29180, 1999.
11. Tanaka M, Kishi Y, Takanezawa Y, Kakehi Y, Aoki J and Arai H: Prostatic acid phosphatase degrades lysophosphatidic acid in seminal plasma. FEBS Lett 571: 197-204, 2004. (Pubitemid 38992948)
12. Japanese Society for Esophageal Disease: Guidelines for the clinical and pathologic studies on carcinoma of the esophagus. 9th edit., Kanehara Publ. Co., Tokyo, 1999.
13. McMillin JB and Dowhan W: Cardiolipin and apoptosis. Biochim Biophys Acta 1585: 97-107, 2002. (Pubitemid 36092073)
14. Murray NR and Fields AP: Phosphatidylglycerol is a physiologic activator of nuclear protein kinase C. J Biol Chem 273: 11514-11520, 1998. (Pubitemid 28272046)
15. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614, 1992.
16. Zhu SC, Li R, Wang YX, Feng W, Li J and Qiu R: Impact of simultaneous assay, the PCNA, cyclinD1, and DNA content with specimens before and after preoperative radiotherapy on prognosis of esophageal cancer-possible incorporation into clinical TNM staging system. World J Gastroenterol 11: 3823-3829, 2005. (Pubitemid 41025231)
17. Yamashita K, Mori M, Shiraishi T, Shibuta K and Sugimachi K: Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma. Clin Cancer Res 6: 1169-1174, 2000. (Pubitemid 30159381)
18. WAF1/Cip1 in the p53-dependent pathway is related to prognosis in patients with advanced esophageal carcinoma. Clin Cancer Res 5: 2445-2449, 1999.
19. Yamamoto S, Tomita Y, Hoshida Y, et al: Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma. Clin Cancer Res 10: 5558-5565, 2004. (Pubitemid 39100496)